TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
758,023
|
491,311
|
314,365 |
| Financial expenses |
201
|
7
|
43 |
| Earnings before taxes |
160,838
|
78,882
|
45,634 |
| EBITDA |
156,674
|
77,224
|
45,958 |
| Total assets |
550,755
|
360,248
|
191,588 |
| Current assets |
548,681
|
358,711
|
190,171 |
| Current liabilities |
364,599
|
262,235
|
131,543 |
| Equity capital |
183,727
|
96,022
|
50,340 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
50
|
48
|
42 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.4%
|
26.7%
|
26.3% |
| Turnover per employee |
15,160
|
10,236
|
7,485 |
| Profit as a percentage of turnover |
21.2%
|
16.1%
|
14.5% |
| Return on assets (ROA) |
29.2%
|
21.9%
|
23.8% |
| Current ratio |
150.5%
|
136.8%
|
144.6% |
| Return on equity (ROE) |
87.5%
|
82.1%
|
90.7% |
| Change turnover |
257,853
|
154,640
|
122,267 |
| Change turnover % |
52%
|
46%
|
64% |
| Chg. No. of employees |
2
|
6
|
5 |
| Chg. No. of employees % |
4%
|
14%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.